Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

PhotoMedex Lifts Q4 Revenue Guidance; Stock Up - Quick Facts

PhotoMedex, Inc. (PHMD: Quote) announced Thursday that it expects revenues for the fourth quarter of 2013 to be more than $60 million without any contribution from Japan, compared with prior guidance issued on November 6, 2013 for revenues for the fourth quarter of 2013 to be more than $55 million without any expected contribution from Japan.

The company attributed the quarterly revenue outperformance to holiday advertising in the Consumer business segment that yielded global direct response sales above prior forecasts, as well as to better-than-expected sales to retail and home shopping channel customers.

Dolev Rafaeli, chief executive officer of PhotoMedex, said, "Consumer demand for no!no! is strong and our advertising spend for the new no!no! Pro during the Christmas holiday season generated a very high media efficiency ratio. In other positive developments, we are experiencing strong patient response to our XTRAC advertising campaign in major markets. We are pleased that for the fourth consecutive quarter XTRAC treatment revenues grew by more than 50% over the prior-year comparison, and for the 12 months ended December 31, 2013 grew by more than 80% over the prior year."

The company expects to release financial results for the fourth quarter of 2013 and hold an investment-community conference call in mid-March 2014.

PHMD closed Tuesday's trading at $12.95. In Thursday's pre-market trading, the company's shares are up $1.35 or 10.42 percent to $14.30.

Register
To receive FREE breaking news email alerts for PhotoMedex Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.